ATI RN Pharmacology 2023 Retake 2 | Nurselytic

Questions 59

ATI RN

Home > ATI RN > ATI Pharmacology > ATI RN Pharmacology 2023 Retake 2
ATI RN Test Bank

ATI RN Pharmacology 2023 Retake 2 Questions

Extract:


Question 1 of 5

A nurse is reviewing the laboratory data of a client who is receiving filgrastim. Which of the following laboratory values should the nurse monitor to evaluate the effectiveness of the treatment?

Correct Answer: A

Rationale: The correct answer is A: WBC count. Filgrastim is a medication that stimulates the production of white blood cells (WBCs). By monitoring the WBC count, the nurse can assess the effectiveness of filgrastim in increasing the client's WBC levels, which is crucial for fighting infections. Monitoring other laboratory values such as INR (choice
B), BUN (choice
C), and potassium level (choice
D) would not directly evaluate the effectiveness of filgrastim in this context. INR is used to monitor blood clotting time, BUN assesses kidney function, and potassium level indicates electrolyte balance, none of which are directly related to the action of filgrastim on WBC production.

Question 2 of 5

Correct Answer:

Rationale:

Question 3 of 5

Correct Answer:

Rationale:

Question 4 of 5

Correct Answer:

Rationale:

Question 5 of 5

Correct Answer:

Rationale:

Similar Questions

A nurse is planning to administer a controlled substance to a client who is experiencing pain. Which of the following actions should the nurse plan to take first?
A nurse is preparing to administer filgrastim 5 mcg/kg/day subcutaneous to a client who weighs 143 lb. How many mcg should the nurse administer per day? (Round the answer to the nearest whole number. Use a leading zero if it applies. Do not use a trailing zero.)
A nurse is caring for a client who is receiving total parenteral nutrition (TPN). The nurse identifies that the client has developed confusion pitting edema. After slowing the infusion rate, which of the following findings should the nurse assess next?
A nurse is reviewing the laboratory data of a client who is receiving filgrastim. Which of the following laboratory values should the nurse monitor to evaluate the effectiveness of the treatment?
A nurse is preparing to administer total parenteral nutrition to a client. Which of the following actions should the nurse take?

Access More Questions!

ATI RN Basic

$89/ 30 days

 

ATI RN Premium

$150/ 90 days